SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMetir Plc Regulatory News (MET)

Share Price Information for Metir Plc (MET)

Share Price is delayed by 15 minutes
Get Live Data
0.85    0.00 (0.00%)
Bid:
0.80
Ask:
0.90
Spread: 0.10 (12.50%)
Market Cap: £3.77m
MET Live PriceLast checked at - London Stock Exchange

Intraday Metir Plc Share Chart

Trading Statement

13 Jan 2026 07:00

RNS Number : 6056O
Metir PLC
13 January 2026
 

 

13 January 2026

Metir plc

 

("Metir", the "Group" or the "Company")

 

Trading Update

 

Metir plc (AIM: MET), the leading global provider of fast-response, mobile and point-of-use water and environmental monitoring technologies, is pleased to provide a trading update for the financial year ended 31 December 2025 ("FY25"). The Group's Annual Report and Accounts are expected to be published in May 2026.

 

Trading in FY25 was in line with management expectations, with growth driven by increased international demand for Microtox® LX instruments, Microtox® reagents and Sulphate Reducing Bacteria ("SRB") kits, alongside continued progress in large-scale potable water monitoring projects with the Continuous Toxic Monitoring ("CTM") installation in Qatar. The Group expects to report revenues of £1.5m (31 December 2024: £0.23m) and a cash balance at the year-end of £1.04m following the successful fundraise of £1.0m, before expenses, completed on 22 December 2025.

 

The Group has continued to build on the momentum reported in its interim results announced on 30 September 2025 and the trading update released on 2 December 2025. Customer demand for Microtox® LX instruments remained strong throughout the second half of the year. Although outsourced manufacturing output increased during H2 2025, production capacity was limited during Q4 2025, constraining the pace at which customer demand could be converted into revenue. Due to these restrictions, 10 of the 56 Microtox® LX instruments ordered in FY25 could not be fulfilled; however, they are now being manufactured and will be delivered in early 2026. Increasing the outsourced manufacturing capacity of Microtox® FX instruments is a key near-term objective in 2026 following increased sales interest.

 

The growing installed base of Microtox® LX and FX instruments is expected to drive demand for high-margin Microtox® reagents. The Board believes that unlocking this high-margin recurring revenue stream is a significant financial objective for the business, with a focus on not only increasing manufacturing capacity, but also working with customers to drive greater reagent usage.

 

Demand for SRB kits, which were relaunched in June 2025, remained robust. Customer interest increased materially, with quotations provided to more than 60 companies worldwide. During Q4 2025, production of SRB kits was temporarily paused due to a manufacturing quality control assessment. The objective is to restart production as soon as practicable, possibly using an alternative biological component to ensure Modern Water's QuickChek™ SRB kit remains the market-leading fast response product.

 

Throughout FY25, the Board continued to prioritise investment in scaling-up manufacturing, product development and commercial capability, consistent with the Group's strategy to build a growing recurring-revenue business for its current product range. In addition, Metir is developing what it believes could be significant future revenue streams from new technologies, including its proprietary mobile PFAS testing technology with Swansea University, and progressing towards completion of the Cryptosporidium project in 2026 with Aptamer Group plc for deployment of a commercial real-time continuous Pathogen Detector.

 

The Group completed a fundraising in December 2025 to strengthen working capital, accelerate manufacturing output and therefore support the conversion of a growing order book into revenue. The Board believes this additional funding materially improves the Group's ability to execute its near-term growth plans and to increase margins on its products.

 

Metir has growing revenues from multiple and diverse Modern Water product streams. Ongoing development of the Group's unique mobile PFAS detection and Pathogen Detection technologies will increase the product portfolio further.

 

Bob Moore, Executive Chairman and Chief Executive Officer of Metir plc, commented:

 

"FY25 marked a year of strong commercial progress for Metir, with customer demand continuing to grow across Modern Water's instrument, reagent and testing kit portfolio. While manufacturing capacity constrained the Group's ability to fully meet demand during the year, the underlying momentum in the business is encouraging for sales growth throughout 2026.

 

"With enhanced funding in place, a growing installed base of instruments and an expanding international pipeline, we enter this year with increased confidence. The Board believes the actions taken during FY25, including further product development, provide a solid foundation for accelerating production of the Group's instrumentation and reagents, driving revenue growth and progressing towards sustainable profitability.

 

"We look forward to reporting progress on the Group's growth initiatives over the coming months."

 

- Ends -

 

Enquiries:

 

Metir plc

Bob Moore, Executive Chairman and Chief Executive Officer

+44 (0) 20 3657 0050

via TPI

 

 

Singer Capital Markets(Nominated Adviser & Joint Broker)

Alex Bond

+44 (0)20 7496 3000

 

 

Turner Pope Investments (TPI) Limited(Joint Broker)

Andrew Thacker / Guy McDougall 

+44 (0) 20 3657 0050

 

Northstar Communications (Investor Relations)

Sarah Hollins

+44 (0) 113 730 3896

 

About Metir

 

Metir plc is a leading global provider of several fast-response, mobile and point-of-use water and environmental monitoring technologies. Through its two established trading divisions, Modern Water and Microsaic Systems, a specialist in mobile PFAS monitoring, the Company develops and supplies innovative, easy-to-use solutions that deliver rapid, accurate water and liquids quality results, helping industries, utilities and regulators monitor safety and compliance in real time.

 

With a strong focus on data-driven insight and field-ready design, Metir's technology supports critical decision-making across sectors, including environmental monitoring, public health and industrial process management.

 

Headquartered in York, UK, Metir serves worldwide customers and is dedicated to advancing water testing standards through innovative, accessible solutions.

 

For more information, please visit: https://www.metirplc.com 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTDXGDBGSBDGLD
Date   Source Headline
1st Dec 20093:51 pmRNSStatement of Investing Policy
30th Sep 200911:04 amRNSInterim Results
30th Sep 20097:00 amRNSInterim Results
28th Aug 200911:59 amRNSResult of AGM
22nd Jul 20093:46 pmRNSHolding(s) in Company
2nd Jul 20092:27 pmRNSHolding(s) in Company
29th Jun 20095:17 pmRNSAnnual Report & Accounts
29th Jun 20094:51 pmRNSHolding(s) in Company
22nd Jun 20097:00 amRNSFinal Results
24th Feb 200910:02 amRNSHolding(s) in Company
19th Jan 200912:22 pmRNSHolding(s) in Company
12th Jan 200912:24 pmRNSHolding(s) in Company
27th Nov 20081:54 pmRNSHolding(s) in Company
13th Nov 20085:02 pmRNSHolding(s) in Company
10th Nov 20083:56 pmRNSHolding(s) in Company
9th Oct 20089:35 amRNSHolding(s) in Company
29th Sep 200811:07 amRNSInterim Results
29th Sep 20087:00 amRNSInterim Results
26th Sep 20087:00 amRNSNotice of Results
25th Sep 20083:17 pmRNSHolding(s) in Company
23rd Jun 200810:11 amRNSResult of AGM - Replacement
23rd Jun 20089:28 amRNSAGM Statement
16th Jun 20089:54 amRNSAnnual Report and Accounts
7th May 20087:01 amRNSFinal Results
2nd May 20083:07 pmRNSNotice of Results
20th Mar 20082:25 pmRNSHolding(s) in Company
11th Jan 20081:01 pmRNSHolding(s) in Company
19th Nov 20073:24 pmRNSHolding(s) in Company
31st Oct 200712:00 pmRNSAppointment of Nomad
27th Sep 20077:04 amRNSInterim Results
27th Sep 20077:03 amRNSAcquisition
24th Sep 20071:14 pmRNSHolding(s) in Company
3rd Sep 200711:51 amRNSHolding(s) in Company
22nd Aug 200711:09 amRNSCancellation of Share Premium
17th Aug 20075:13 pmRNSAIM Rule 26
13th Jul 200710:25 amRNSHolding(s) in Company
12th Jul 20073:42 pmRNSHolding(s) in Company
11th Jul 20079:06 amRNSAcquisition-Replacement
11th Jul 20077:00 amRNSAcquisition
21st Jun 20077:00 amRNSAppointment of Joint Broker
18th Jun 20077:04 amRNSProperty Acquisition
14th Jun 20074:58 pmRNSHolding(s) in Company
13th Jun 20075:04 pmRNSHolding(s) in Company
13th Jun 20073:39 pmRNSHolding(s) in Company
12th Jun 20072:45 pmRNSHolding(s) in Company
11th May 20078:00 amRNSRe: Board Announcement
8th May 20077:02 amRNSRe: First Investment
30th Mar 20074:54 pmRNSHolding(s) in Company
22nd Dec 200611:39 amRNSHolding(s) in Company
22nd Dec 200611:36 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.